Sold as Carbon Dioxide, USP, Carbon Dioxide, Usp. Every FDA application for this active ingredient.
As of Nov 15, 2026, FDA lists 2 applications for Carbon Dioxide, USP (sold as Carbon Dioxide, USP, Carbon Dioxide, Usp), first approved Nov 9, 2024, with 0 new uses approved and 0 published complete response letters.
| Study | Phase | Status | Posted |
|---|---|---|---|
| Investigation of Laser Assisted Drug Delivery of NanoDOX®Wounds and Injury · Massachusetts General Hospital | Phase 2 | Active, not recruiting | Jun 9, 2022 |
| Nov 9, 2024 | Carbon Dioxide, USPNDA 220050 | Djb Gas Services, Inc | 0 | Marketed |
| Sep 22, 2026 | Carbon Dioxide, UspNDA 222000 | Agl Welding Supply Co Inc Dba Agl Gas Technologies | 0 | Marketed |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
